| Varsha Raghavan, DO | |
|
126 Auburn Ave Ste 300, Auburn, WA 98002-5082 | |
| (253) 735-0166 | |
| Not Available |
| Full Name | Varsha Raghavan |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 126 Auburn Ave Ste 300, Auburn, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730612508 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | OP61070926 (Washington) | Primary |
| Entity Name | Healthpoint |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831199454 PECOS PAC ID: 9335042886 Enrollment ID: O20040206000245 |
News Archive
Alkermes plc today announced the initiation of the second phase 2 study of ALKS 3831, a novel, oral, broad-spectrum antipsychotic medicine in development for schizophrenia.
Epithelial ovarian cancer (EOC) is the most lethal disease among gynecologic malignancies. Patients with an advanced disease often relapse due to the development of chemoresistance. Chemotherapy failure is a consequence of acquired drug resistance which may potentially be due to multiple mechanisms including miRNA-mediated gene regulation.
Researchers at OHSU's OGI School of Science & Engineering have launched a unique, new research project that will use advanced speech and language technologies to better understand childhood communication disorders.
The Michael J. Fox Foundation for Parkinson's Research has awarded Durin Technologies, Inc., a grant of $351,200 to expand the development of Durin's novel blood test that can detect the presence of Parkinson's disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Varsha Raghavan, DO 955 Powell Ave Sw, Renton, WA 98057-2908 Ph: (425) 277-1311 | Varsha Raghavan, DO 126 Auburn Ave Ste 300, Auburn, WA 98002-5082 Ph: (253) 735-0166 |
News Archive
Alkermes plc today announced the initiation of the second phase 2 study of ALKS 3831, a novel, oral, broad-spectrum antipsychotic medicine in development for schizophrenia.
Epithelial ovarian cancer (EOC) is the most lethal disease among gynecologic malignancies. Patients with an advanced disease often relapse due to the development of chemoresistance. Chemotherapy failure is a consequence of acquired drug resistance which may potentially be due to multiple mechanisms including miRNA-mediated gene regulation.
Researchers at OHSU's OGI School of Science & Engineering have launched a unique, new research project that will use advanced speech and language technologies to better understand childhood communication disorders.
The Michael J. Fox Foundation for Parkinson's Research has awarded Durin Technologies, Inc., a grant of $351,200 to expand the development of Durin's novel blood test that can detect the presence of Parkinson's disease.
› Verified 7 days ago
Tanja D Evans, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 202 N Division St Ste 202, Auburn, WA 98001 Phone: 253-876-8088 | |
Bradley Thor Kuske, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 121 N Division St Ste 310, Auburn, WA 98001 Phone: 253-372-7121 | |
Beth W. Nauert, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 126 Auburn Ave Ste 300, Auburn, WA 98002 Phone: 537-350-1662 Fax: 253-833-8987 | |
Daniel Antonio Delgado, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 126 Auburn Ave Ste 300, Auburn, WA 98002 Phone: 253-735-0166 | |
Dr. Margarita Maria Guerra, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2709 V Ct Se, Auburn, WA 98002 Phone: 253-804-4065 | |
Raymond R Myers, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 202 N Division St Ste 202, Auburn, WA 98001 Phone: 253-846-8088 Fax: 253-846-8079 |